7SBio bags $10 mln Series C

Seventh Sense Biosystems Inc, a maker of a blood collection device, has secured $10 million in Series C funding. The investors were Novartis, Laboratory Corporation of America Holdings, Polaris Partners and Flagship Ventures. In conjunction with the funding, Marc Ceulemans, head of strategic venture capital and pharma equities at Novartis and Don Hardison, former CEO of Good Start Genetics, have been added to 7SBio's board of directors. Also, Seventh Sense has hired Stuart Blitz as its chief business officer.

North AmericaUSBriefs